Last reviewed · How we verify
Schistosomiasis due to S. Haematobium
Approved treatments
- Cysticide · Merck KGaA, Darmstadt, Germany
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Schistosomiasis due to S. Haematobium patent landscape — cliff calendar, originator estates, attackable patents
- Schistosomiasis due to S. Haematobium treatment landscape brief
- Schistosomiasis due to S. Haematobium treatment updates RSS
Frequently asked questions about Schistosomiasis due to S. Haematobium
What drugs treat Schistosomiasis due to S. Haematobium?
Tracked treatments include Cysticide.
What is the treatment for Schistosomiasis due to S. Haematobium?
Standard treatment for Schistosomiasis due to S. Haematobium includes Cysticide. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Schistosomiasis due to S. Haematobium patent cliff · Schistosomiasis due to S. Haematobium CI report
- Treatment: Cysticide · Merck KGaA, Darmstadt, Germany
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing